• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

颈动脉超声评估的亚临床颈动脉粥样硬化与中青年男性非酒精性脂肪性肝病纤维化评分的相关性。

Association of subclinical carotid artery atherosclerosis assessed by carotid ultrasound with nonalcoholic fatty liver disease fibrosis score in young and middle-aged men.

机构信息

Department of Cardiology, Faculty of Medicine, Recep Tayyip Erdoğan University, Rize, Turkey.

出版信息

Int J Cardiovasc Imaging. 2024 Sep;40(9):1979-1986. doi: 10.1007/s10554-024-03193-w. Epub 2024 Jul 16.

DOI:10.1007/s10554-024-03193-w
PMID:39012403
Abstract

BACKGROUND

Non-alcoholic Fatty Liver Disease (NAFLD) is a widespread liver disorder caused by excess fat accumulation in the liver with no significant alcohol consumption. This condition has been linked to the development of cardiovascular diseases (CVD) and atherosclerosis. Carotid intima-media thickness (CIMT) and carotid plaques, which are established markers of subclinical atherosclerosis, were used to assess CVD risk. However, few studies have explored the correlation between NAFLD and subclinical atherosclerosis, especially in young and middle-aged men. A study on 200 male patients aged 18-55 years aimed to investigate the association between NAFLD fibrosis score (NFS) and CIMT, as well as carotid plaque presence.

METHODS

The study, conducted between July 2023 and January 2024, included CIMT measurements and plaque assessments performed using B-mode ultrasound. Participants were divided into two groups based on CIMT values and plaque presence, and NFS was analyzed for its association with CIMT and plaque.

RESULTS

Participants with higher CIMT values had a significantly higher NFS (-2.9 ± 1.13 vs. -1.9 ± 1.4, P < 0.001) than those with lower CIMT values. Similarly, participants with carotid plaque also exhibited a higher NFS (-2.5 ± 1.3 vs. -1.7 ± 1.4, P = 0.002). Multivariate logistic regression analysis showed that NFS was a strong predictor of both increased CIMT (odds ratio [OR]: 1.564%95 CI 1.035-2.363; P = 0.034) and carotid plaque presence (OR: 1.605%95 CI 1.118-2.290; P = 0.010).

CONCLUSION

These results emphasize the potential role of NFS as a marker of subclinical atherosclerosis in young and middle-aged men.

摘要

背景

非酒精性脂肪性肝病(NAFLD)是一种广泛存在的肝脏疾病,其特征是肝脏内脂肪堆积过多,而无明显的酒精摄入。这种情况与心血管疾病(CVD)和动脉粥样硬化的发展有关。颈动脉内膜中层厚度(CIMT)和颈动脉斑块是动脉粥样硬化亚临床的既定标志物,用于评估 CVD 风险。然而,很少有研究探讨 NAFLD 与亚临床动脉粥样硬化之间的相关性,尤其是在年轻和中年男性中。一项针对 200 名年龄在 18-55 岁的男性患者的研究旨在探讨 NAFLD 纤维化评分(NFS)与 CIMT 以及颈动脉斑块存在之间的关系。

方法

该研究于 2023 年 7 月至 2024 年 1 月进行,包括使用 B 型超声进行 CIMT 测量和斑块评估。根据 CIMT 值和斑块的存在,将参与者分为两组,并分析 NFS 与 CIMT 和斑块之间的关系。

结果

CIMT 值较高的参与者的 NFS 显著较高(-2.9±1.13 与-1.9±1.4,P<0.001),而 CIMT 值较低的参与者的 NFS 较低。同样,颈动脉斑块患者的 NFS 也较高(-2.5±1.3 与-1.7±1.4,P=0.002)。多变量逻辑回归分析表明,NFS 是 CIMT 增加(比值比 [OR]:1.564%95%置信区间 [CI]:1.035-2.363;P=0.034)和颈动脉斑块存在(OR:1.605%95%CI:1.118-2.290;P=0.010)的强有力预测因素。

结论

这些结果强调了 NFS 作为年轻和中年男性亚临床动脉粥样硬化标志物的潜在作用。

相似文献

1
Association of subclinical carotid artery atherosclerosis assessed by carotid ultrasound with nonalcoholic fatty liver disease fibrosis score in young and middle-aged men.颈动脉超声评估的亚临床颈动脉粥样硬化与中青年男性非酒精性脂肪性肝病纤维化评分的相关性。
Int J Cardiovasc Imaging. 2024 Sep;40(9):1979-1986. doi: 10.1007/s10554-024-03193-w. Epub 2024 Jul 16.
2
Advanced fibrosis associates with atherosclerosis in subjects with nonalcoholic fatty liver disease.在非酒精性脂肪性肝病患者中,晚期肝纤维化与动脉粥样硬化相关。
Atherosclerosis. 2015 Jul;241(1):145-50. doi: 10.1016/j.atherosclerosis.2015.05.002. Epub 2015 May 6.
3
Association between nonalcoholic fatty liver disease and subclinical atherosclerosis: a cross-sectional study on population over 40 years old.非酒精性脂肪性肝病与亚临床动脉粥样硬化之间的关联:一项针对40岁以上人群的横断面研究。
BMC Cardiovasc Disord. 2018 Jul 16;18(1):147. doi: 10.1186/s12872-018-0877-2.
4
Multi-view carotid ultrasound is stronger associated with cardiovascular risk factors than presence of plaque or single carotid intima media thickness measurements in subclinical atherosclerosis.多视角颈动脉超声与心血管危险因素的相关性强于亚临床动脉粥样硬化斑块或单一颈动脉内膜中层厚度测量。
Int J Cardiovasc Imaging. 2023 Aug;39(8):1461-1471. doi: 10.1007/s10554-023-02868-0. Epub 2023 May 30.
5
Improvement in non-alcoholic fatty liver disease severity is associated with a reduction in carotid intima-media thickness progression.非酒精性脂肪性肝病严重程度的改善与颈动脉内膜中层厚度进展的降低相关。
Atherosclerosis. 2016 Mar;246:13-20. doi: 10.1016/j.atherosclerosis.2015.12.028. Epub 2015 Dec 24.
6
Carotid plaque burden as a measure of subclinical atherosclerosis: comparison with other tests for subclinical arterial disease in the High Risk Plaque BioImage study.颈动脉斑块负荷作为亚临床动脉粥样硬化的衡量指标:在高危斑块生物图像研究中与其他亚临床动脉疾病检测方法的比较。
JACC Cardiovasc Imaging. 2012 Jul;5(7):681-9. doi: 10.1016/j.jcmg.2012.03.013.
7
The relationship between carotid intima-media thickness and carotid plaque in the Northern Manhattan Study.北曼哈顿研究中颈动脉内膜中层厚度与颈动脉斑块的关系。
Atherosclerosis. 2015 Aug;241(2):364-70. doi: 10.1016/j.atherosclerosis.2015.05.027. Epub 2015 Jun 3.
8
Comparison of carotid intima-media thickness and coronary artery calcium score for estimating subclinical atherosclerosis in patients with fatty liver disease.比较颈动脉内膜中层厚度和冠状动脉钙化积分以评估脂肪肝患者的亚临床动脉粥样硬化
Cardiovasc J Afr. 2018;29(2):93-98. doi: 10.5830/CVJA-2017-052. Epub 2017 Dec 8.
9
Associations of subclinical atherosclerosis with nonalcoholic fatty liver disease and fibrosis assessed by non-invasive score.通过无创评分评估亚临床动脉粥样硬化与非酒精性脂肪性肝病及纤维化的相关性。
Liver Int. 2020 Apr;40(4):806-814. doi: 10.1111/liv.14322. Epub 2019 Dec 27.
10
High NAFLD fibrosis score in non-alcoholic fatty liver disease as a predictor of carotid plaque development: a retrospective cohort study based on regular health check-up data in China.非酒精性脂肪性肝病纤维化评分高可预测颈动脉斑块形成:基于中国常规健康检查数据的回顾性队列研究。
Ann Med. 2021 Dec;53(1):1621-1631. doi: 10.1080/07853890.2021.1974081.

引用本文的文献

1
Association between albumin-bilirubin score and sarcopenia in middle-aged Americans: a cross-sectional study.美国中年人群中白蛋白-胆红素评分与肌肉减少症的关联:一项横断面研究。
Front Nutr. 2025 Jul 4;12:1606854. doi: 10.3389/fnut.2025.1606854. eCollection 2025.
2
Associations between MASLD phenotypes and the risk of carotid artery plaque: a cross-sectional study among railway workers.代谢功能障碍相关脂肪性肝病(MASLD)表型与颈动脉斑块风险之间的关联:一项铁路工人的横断面研究
Acta Diabetol. 2025 Jun 24. doi: 10.1007/s00592-025-02536-w.
3
Bridging the gap in obesity research: A consensus statement from the European Society for Clinical Investigation.

本文引用的文献

1
Systematic review and meta-analysis: Association between liver fibrosis and subclinical atherosclerosis in nonalcoholic fatty liver disease.系统评价和荟萃分析:非酒精性脂肪性肝病患者肝纤维化与亚临床动脉粥样硬化的相关性。
Aliment Pharmacol Ther. 2023 Aug;58(4):384-394. doi: 10.1111/apt.17617. Epub 2023 Jun 22.
2
Metabolic dysfunction-associated fatty liver disease increased the risk of subclinical carotid atherosclerosis in China.代谢相关脂肪性肝病增加中国人群亚临床颈动脉粥样硬化风险。
Front Endocrinol (Lausanne). 2023 Apr 4;14:1109673. doi: 10.3389/fendo.2023.1109673. eCollection 2023.
3
Endotheliopathy in the metabolic syndrome: Mechanisms and clinical implications.
弥合肥胖研究差距:欧洲临床研究学会的共识声明
Eur J Clin Invest. 2025 Aug;55(8):e70059. doi: 10.1111/eci.70059. Epub 2025 May 15.
代谢综合征中的血管内皮病变:机制与临床意义。
Pharmacol Ther. 2023 Apr;244:108372. doi: 10.1016/j.pharmthera.2023.108372. Epub 2023 Mar 7.
4
The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis.全球非酒精性脂肪性肝病的患病率和发病率:系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2022 Sep;7(9):851-861. doi: 10.1016/S2468-1253(22)00165-0. Epub 2022 Jul 5.
5
A significant risk of metabolic dysfunction-associated fatty liver disease plus diabetes on subclinical atherosclerosis.代谢功能障碍相关脂肪性肝病合并糖尿病与亚临床动脉粥样硬化的显著相关性风险。
PLoS One. 2022 May 31;17(5):e0269265. doi: 10.1371/journal.pone.0269265. eCollection 2022.
6
Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: An updated meta-analysis with 135,602 individuals.非酒精性脂肪性肝病增加颈动脉粥样硬化和缺血性卒中的风险:一项包含 135602 人的更新荟萃分析。
Clin Mol Hepatol. 2022 Jul;28(3):483-496. doi: 10.3350/cmh.2021.0406. Epub 2022 Mar 2.
7
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.2021年欧洲心脏病学会临床实践心血管疾病预防指南。
Eur J Prev Cardiol. 2022 Feb 19;29(1):5-115. doi: 10.1093/eurjpc/zwab154.
8
High NAFLD fibrosis score in non-alcoholic fatty liver disease as a predictor of carotid plaque development: a retrospective cohort study based on regular health check-up data in China.非酒精性脂肪性肝病纤维化评分高可预测颈动脉斑块形成:基于中国常规健康检查数据的回顾性队列研究。
Ann Med. 2021 Dec;53(1):1621-1631. doi: 10.1080/07853890.2021.1974081.
9
The progression and regression of metabolic dysfunction-associated fatty liver disease are associated with the development of subclinical atherosclerosis: A prospective analysis.代谢功能障碍相关脂肪性肝病的进展和消退与亚临床动脉粥样硬化的发生有关:一项前瞻性分析。
Metabolism. 2021 Jul;120:154779. doi: 10.1016/j.metabol.2021.154779. Epub 2021 Apr 23.
10
NAFLD and cardiovascular diseases: a clinical review.非酒精性脂肪性肝病与心血管疾病:临床综述。
Clin Res Cardiol. 2021 Jul;110(7):921-937. doi: 10.1007/s00392-020-01709-7. Epub 2020 Jul 21.